Invivodata’s COA smarts to ease electronic migration of UCB trial instrument
UCB has called on the Clinical Outcome Assessment (COA) expertise of invivodata to help it migrate from paper-based to electronic administration of a commonly used ClinRO (clinician-reported outcomes) instrument in evaluating a new product for rheumatoid arthritis (RA).
Read More




